Munich, Germany, April 17th 2020: Nanion Technologies GmbH, a leading provider of automated patch clamp and cell monitoring systems, announces the partnership with NEXEL Co., Ltd., specialists in the manufacturing of hiPSC-derived cells. Under the partnership NEXEL will provide demonstration infrastructure in South Korea for Nanion´s CardioExcyte 96 and FLEXcyte 96 cell monitoring systems, while Nanion will provide scientific proficiency in experimental design and assay development. 

Read the full press release .here